Ekso Bionics regains Nasdaq minimum bid price compliance

EKSO BIONICS HOLDINGS, INC.

Received Nasdaq written notice on Nov 14, 2023, confirming compliance with $1.00 minimum bid price rule.
Previous deficiency notice was received on Sept 29, 2023, for 30 consecutive business days below $1.00.
Nasdaq has closed the matter; no further delisting risk from this issue.
Common stock continues trading on Nasdaq Capital Market under ticker EKSO.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.